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BACKGROUND: Multidisciplinary care is advocated as an effective chronic kidney disease treatment pro-
gram in a few, but not all, studies. Our study aimed to evaluate the effect of multidisciplinary care on renal
outcome and patient survival using a larger cohort.
METHOD: A total 1382 chronic kidney disease patients, ages 18-80 years, with chronic kidney disease stage
3B-5, in nephrology outpatient clinics were enrolled. Using age, sex, chronic kidney disease stage, and dia-
betes mellitus as variables, 592 multidisciplinary care program participants were matched with 614 non-
multidisciplinary care patients. The primary outcomes were long-term renal replacement therapy and mortality.
Secondary outcomes included changes of biochemical markers and blood pressure, infection hospitalization,
cardiovascular events, and emergent start of long-term dialysis. Annual medical costs were compared.
RESULTS: There were no between-group differences regarding mortality. In the multivariate competing-risk
regression model, the multidisciplinary care group had a better renal survival (hazard ratio 0.640; 95%
conﬁdence interval, 0.484-0.847; P ¼ .002). This effect was most prominent in stage 4 (hazard ratio 0.375;
95% conﬁdence interval, 0.219-0.640; P < .001), but not in stage 3B and 5 patients. The multidisciplinary
care group showed a slower estimated glomerular ﬁltration rate decline (2.57 vs 3.74 mL/min/1.73 m2,
P ¼ .021), and a smaller increase in phosphate (þ 0.03 vs þ 0.33 mg/dL, P ¼ .013). Cardiovascular and
infection events were both decreased in the multidisciplinary care group (P < .001). There was also less
requirement of emergent start dialysis (39.6% vs 54.5%, P ¼ .001). The annual cost for the multidisci-
plinary care group was lower than the nonmultidisciplinary care group (US $2372 vs $3794, P < .001). In
addition, considering the reduction of patients requiring renal replacement therapy, the multidisciplinary
care program saved a total US $1931 per patient annually.
CONCLUSIONS: Our analysis demonstrated that the multidisciplinary care program provided better health
care and reduced renal replacement therapy in patients with advanced chronic kidney disease. By
decreasing hospitalizations, emergent start, and the need for renal replacement therapy, the multidisci-
plinary care program was cost-effective.
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Chen et al Multidisciplinary Care Provides Better Care in Chronic Kidney Disease 69The incidence of end-stage renal disease in most countries is
increasing. Chronic kidney disease, the major cause of
end-stage renal disease, is associated with increased risk of
comorbidities and mortality. Finding an effective treatment
to prevent the progression is an important issue.
Multidisciplinary care is an integrative medical careCLINICAL SIGNIFICANCE
 This study demonstrated the beneﬁcial
effect of a multidisciplinary care pro-
gram in chronic kidney disease patients.
 Patients in a multidisciplinary care pro-
gram had a beneﬁt of risk reduction of
33.6% renal replacement therapy
compared with patients not receiving
this program.
 Patients receiving a multidisciplinary
care program had less chance of admis-
sion or emergent dialysis.
 A multidisciplinary care program is cost-
effective.system that includes doctors,
nurses, and dietitians to participate
in the medical treatment, patient
education, diet consultation, be-
havior adjustment, and close
monitoring system. Earlier studies
demonstrated that multidiscipli-
nary care participants were better
prepared for dialysis.1 There were
also beneﬁcial effects on patient
overall survival, laboratory para-
meters,2,3 less unplanned dialysis,
and lower incidence of cardiovas-
cular events.4 However, there was
a report revealing no beneﬁcial
effect on renal function progres-
sion.5 The initial report of the
Multifactorial Approach and Su-
perior Treatment Efﬁcacy in Renal
Patients with the aid of Nurse
practitioners (MASTERPLAN) study did not reveal im-
provement on cardiovascular outcomes, all-cause mortality
and end-stage renal disease.6 However, the extended
follow-up showed a better composite outcome of end-stage
renal disease, death, or 50% increase of creatinine.7
Taiwan initiated a nationwide multidisciplinary care
program for stage 3B-5 chronic kidney disease patients in
November 2006, after that a slower renal function deterio-
ration was found.8,9 A survey revealed a progressive
decrease of end-stage renal disease incidence since 2007.10
However, several studies in Taiwan showed a contradictory
effect. One observation showed that multidisciplinary care
was associated with a slower decline rate of estimated
glomerular ﬁltration rate (eGFR) and less initiation of
dialysis.11 In central Taiwan, multidisciplinary care partici-
pants had paradoxically more long-term dialysis.12
To provide evidenced-based data for the exact beneﬁt of
a multidisciplinary care program, we conducted a retro-
spective study to evaluate the effect of this program on
dialysis incidence, eGFR decline, patient survival, change of
biochemical markers, and medical costs.
METHODS
Participants
We performed a retrospective single-center analysis in Na-
tional Taiwan University Hospital. Patients ages 18-80 years
who were diagnosed with chronic kidney disease stage 3B-5
for at least 3 months and joined the pre-end-stage renal
disease multidisciplinary care program between 2007 and
2009 were included. These patients were deﬁned as amultidisciplinary care group. We excluded patients who
have had a kidney transplant, had acute kidney injury, ever
received renal replacement therapy, had Child Pugh class
B-C liver cirrhosis, and had terminal malignancies. We used
a 4-variable equation from the Modiﬁcation of Diet in Renal
Disease-4 equation (186  Scr1.154  Age 0.203  0.742(if female)  1.212) to estimate
eGFR.
For the comparison group
(nonmultidisciplinary care group),
we choose patients not entering
the multidisciplinary care program
during the same period and treated
at our nephrology outpatient clinic
with the diagnosis of International
Classiﬁcation of Disease, 9th
Revision codes 585 and 582. The
inclusion and exclusion criteria
were the same as the multidisci-
plinary care program recipients.
We further matched those com-
parison group patients with
multidisciplinary care group pa-
tients by chronic kidney disease
stage, age, sex, and diabetes. All
patients in the multidisciplinarycare and nonmultidisciplinary care group were treated ac-
cording to the Kidney Disease Outcomes Quality Initiative
guidelines.13 This study was approved by the National
Taiwan University Hospital Research Ethics Committee.
Multidisciplinary Care Program
The multidisciplinary care program integrated the care of
nephrologists, nurses, dieticians, and pharmacists. On
visiting our nephrology clinic, those with eGFR 45 mL/min
per 1.73 m2 were all requested by the physician to join the
program. The nursing staff conducted a detailed interview
with the patients, consisting of basic knowledge of chronic
kidney disease, lifestyle modiﬁcation, clarifying risk factors,
and condition of end-stage renal disease. Dietician consul-
tation was conducted at the same time. The participants
return to the clinic every 1-3 months, according to the
judgments of primary care nephrologists. The educational
programs conducted by the nursing staff and routine labo-
ratory tests are required at least every 3 months. The
registration fee was US $40 and annual fee was US $150
(stage 3B-4) or US $180 (stage 5). Once the patients entered
chronic kidney disease stage 5, they were invited to visit our
dialysis center to receive dialysis education regarding the
modality of renal replacement therapy. Preparation of the
hemodialysis vascular access or peritoneal dialysis catheter
was encouraged when suitable.
Data Collections
Data of age, sex, underlying diseases, and comorbidity
were recorded. The deﬁnition of cardiovascular disease
70 The American Journal of Medicine, Vol 128, No 1, January 2015comprised congestive heart failure, coronary artery disease,
cerebral vascular disease, and peripheral vascular disease.
Medical records were reviewed to document the use
of angiotensin-converting enzyme inhibitors (ACEIs) or
angiotensin receptor blockers (ARBs), the hospitalizations
due to cardiovascular events or infection. The blood pres-
sure (BP) and biochemical data, including creatinine,
hemoglobin, calcium, phosphorus, albumin level, and urine
protein-to-creatinine ratio were recorded at baseline and
then annually. For those who initiated long-term renal
replacement therapy, the modality and the use of a tempo-
rary catheter were recorded. Our Medical Affairs Ofﬁce
provided the data on medical costs. Costs were calculated
through December 31, 2012. For those who started hemo-
dialysis or peritoneal dialysis, all costs from enrollment until
the establishment of long-term dialysis catheter were
calculated. For those who received preemptive renal trans-
plantation, medical costs were recorded until just before the
transplantation operation.Outcomes
The primary outcomes of the study were all-cause mortality
and initiation of long-term renal replacement therapy,
including hemodialysis, peritoneal dialysis, or renal trans-
plantation. For all those who started renal replacement
therapy, we further analyzed whether they received emer-
gent start of dialysis. Emergent start was deﬁned as un-
planned long-term dialysis with temporary catheter.
Temporary dialysis due to acute kidney injury was not
included. For those who received long-term hemodialysis,
the initial vascular access was documented. Secondary
outcomes included annual change of biochemical markers
and BP, cardiovascular and infection hospitalization, and
the need of emergent start of dialysis. For those who start
renal replacement therapy within 1 year, the eGFR upon
dialysis initiation was used to calculate the eGFR decline
rate. Medical costs were also compared between groups.
Patients were followed-up until reaching primary endpoints
or until December 31, 2012.Statistical Analysis
Baseline characteristics were described as mean  SD for
continuous variables, and frequency for categorical vari-
ables. The differences were analyzed using t-test and
chi-squared test. Skewed variables, such as urine protein-
creatinine ratio and the eGFR on dialysis initiation, were
compared by Mann-Whitney U test. Event rates were
compared by Poisson test.
Considering the potential of the competing risk of end-
stage renal disease and death before end-stage renal
disease, a competing risks model was used and cumulative
incidence functions of end-stage renal disease were calcu-
lated, treating death as a competing event. Fine and Gray
proportional hazards regression models were used to esti-
mate the effect of multidisciplinary care program on therisks of end-stage renal disease and mortality. The sub-
distribution hazards ratios (HRs) from the model were
determined to account for competing risk. Covariates
adjusted in the regression model included: age, sex, diabetes
mellitus, cardiovascular disease, systolic BP, eGFR, albu-
min, calcium and phosphate product, and log urine protein-
creatinine ratio. In full model, the use of ACEIs/ARBs was
included. HRs and 95% conﬁdence intervals (CIs) were
calculated for the association between multidisciplinary care
and outcome.
The medical costs were estimated by multiplying the
survival probability with the corresponding medical costs
after adjusting an annual 3% discount rate. Per patient-year
costs were further calculated by dividing the mean survival.
The differences of medical costs were compared by Z-test.
All statistical tests were 2-tailed, and a P-value of < .05
was considered signiﬁcant. The statistical analyses were
performed with the use of SPSS version 19 (IBM, Armonk,
NY) and STATA version 12 (StataCorp LP, College
Station, TX). The medical costs were analyzed by ISQoL
(http://www.stat.sinica.edu.tw/isqol/).RESULTS
Baseline Characteristics
A total 1382 patients were enrolled, including 721 multi-
disciplinary care group and 661 nonmultidisciplinary care
group patients. Using age, sex, chronic kidney disease
stage, and diabetes mellitus status as variables, 592 multi-
disciplinary care recipients were matched to 614 non-
multidisciplinary care patients (Figure 1). The median
follow-up time was 2.43 years. Most patients lived in
metropolitan Taipei, and there were no differences between
groups (87.2% vs 87.3%, P ¼ .944). There were no dif-
ferences regarding age, sex, body mass index, eGFR, and all
major comorbidities (Table 1). The nonmultidisciplinary
care group had higher BP, phosphate, and urine protein
creatinine ratio. Baseline albumin and calcium were higher
in the multidisciplinary care group, and there were no
differences regarding hemoglobin level, uric acid, and the
prescription of ACEI/ARB.Survival Analysis
During the follow-up period, the mortality rates were 7.6%
and 5.9% in multidisciplinary and nonmultidisciplinary
groups, respectively (P ¼ .329), which was not signiﬁ-
cantly different. Divided by chronic kidney disease stages,
there were also no differences in stage 3B (9.6% vs 10.0%,
P ¼ .892), stage 4 (9.2% vs 5.9%, P ¼ .195), and stage 5
(4.1% vs 2.7%, P ¼ .435). Long-term renal replacement
therapy was initiated in 230 patients (38.9%) in the multi-
disciplinary care group, and 319 patients (52.0%) in the
nonmultidisciplinary care group. All patients started renal
replacement therapy with an eGFR <15 mL/min/1.73m2,
and there was no difference in eGFR upon initiating renal
replacement therapy (4.47 vs 4.40 mL/min/1.73m2,
Figure 1 Study design, inclusion and exclusion criteria, and allocation of patients.
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incidence of renal replacement therapy was lower in the
multidisciplinary care group (P < .001, Figure 2A). In the
subgroup analysis, renal outcome was better in chronic
kidney disease stage 4 (P < .001) and stage 5 (P ¼ .01)
patients (Figure 2C, D), but not in stage 3 patients
(P ¼ .44) (Figure 2B).
In the Fine and Gray competing regression model, the
multidisciplinary care program had a renoprotective effect,
with crude HR 0.675 (95% CI, 0.570-0.800; P < .001). After
adjusting demographic data, comorbidities, and biochemical
data (Model 1), the multidisciplinary care program was a
strong factor to reduce the risk of renal replacement therapy
(HR 0.641; 95% CI, 0.483-0.851; P ¼ .002). Considering
the possible effect of ACEI/ARB in Model 2, multidisci-
plinary care program was associated with a 36.0% risk
reduction (95% CI, 0.484-0.847; P ¼ .002) (Table 2).
Dividing the patients according to different chronic kidney
disease stages, a lower rate of renal replacement was
observed in stage 4 multidisciplinary care program
participants (HR 0.375; 95% CI, 0.219-0.640; P < .001 in
model 2). Stage 3B multidisciplinary care program
participants had a 47.8% risk reduction, though it was not
statistically signiﬁcant (P ¼ .195). The stage 5 participantshad a better outcome with crude HR (0.757, P ¼ .011),
but this effect was not signiﬁcant on multivariable
adjustment (P ¼ .194) (Table 2).Secondary Outcomes
The multidisciplinary care group had a signiﬁcantly slower
annual eGFR decline rate (2.57 vs 3.74 mL/min/1.73
m2, P ¼ .021). In a different stage, the multidisciplinary care
group had lower but insigniﬁcant eGFR decline rates. Better
phosphate control was noted in the multidisciplinary care
group (þ0.03 vs þ0.33 mg/dL, P ¼ .013). The multidisci-
plinary care group also showed some favorable annual
biochemical change, such as hemoglobin (0.11 vs 0.24
g/dL, P ¼ .269) and urine protein-creatinine ratio (þ0.379
vs þ0.557 g/g, P ¼ .474), although they were not statisti-
cally signiﬁcant. There was no difference regarding BP
control and change of albumin level between groups
(Table 3).
During the follow-up period, the multidisciplinary care
group had fewer adverse cardiovascular (0.04 vs 0.10 times
per person-year, P < .001) and infection events (0.07 vs
0.12 times per person-year, P < .001). Hospitalization days
due to the above reasons were also signiﬁcantly shorter
Table 1 Baseline Characteristics Between Multidisciplinary Care and Nonmultidisciplinary Care Groups
Multidisciplinary Care Group
n ¼ 592
Nonmultidisciplinary Care Group
n ¼ 614 P-Value
Age 62.16  13.16 61.93  13.68 .764
Sex (male) 57.9% 53.6% .128
Body mass index (Kg/m2) 24.79  4.42 24.47  4.27 .214
eGFR (mL/min/1.73m2) 22.41  11.64 22.05  12.14 .601
Chronic kidney disease stage .276
Stage 3B 31.8% 27.7%
Stage 4 35.0% 36.0%
Stage 5 33.3% 36.3%
Diabetes mellitus 44.3% 45.0% .808
Hypertension 95.8% 95.3% .675
Cardiovascular disease 32.3% 34.0% .513
Liver disease 9.5% 11.9% .172
Cancer 13.0% 12.9% .942
Systolic blood pressure (mm Hg) 133.08  18.11 136.26  18.16 .003
Diastolic blood pressure (mm Hg) 75.75  11.15 78.76  12.16 <.001
Hemoglobin (g/dL) 10.88  2.05 10.67  2.23 .102
Albumin (g/dL) 4.34  0.43 4.06  0.61 <.001
Calcium (mmol/L) 2.26  0.17 2.15  0.22 <.001
Phosphate (mg/dL) 4.11  1.00 4.62  1.36 <.001
Uric acid (mg/dL) 8.26  1.96 8.27  2.10 .939
Urine protein creatinine ratio (g/g) 1.230 (0.499-2.748) 2.078 (0.851-4.294) <.001
ACEI/ARB 57.9% 56.0% .502
Continuous variables were compared using t-test and categorical variables were compared using chi-squared test.
Urine protein creatinine ratio was expressed as median (25th and 75th quartile) and compared by Mann-Whitney U test.
ACEI ¼ angiotensin-converting enzyme inhibitor; ARB ¼ angiotensin receptor blocker; eGFR ¼ estimated glomerular ﬁltration rate.
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signiﬁcantly more emergency department visits (P < .001).
On the other hand, the outpatient visits between groups
showed no difference. The multidisciplinary care group
was better prepared, with fewer patients requiring
emergent start of dialysis (39.6% vs 54.5%, P ¼ .001).
For those receiving long-term hemodialysis, the multidis-
ciplinary care group was better prepared with arteriovenous
ﬁstula or graft (46.6% vs 28.2%) There was no signiﬁcant
difference between groups in long-term renal replacement
modalities (P ¼ .060) (Table 3).Medical Costs
The multidisciplinary care group had a signiﬁcantly lower
annual cost per patient year (US $2372 vs $3794, P < .001)
and had less spent on emergency department (US $104 vs
$189, P < .001) and inpatient treatment (US $829 vs $2128,
P < .001). The cost of outpatient care was not signiﬁcantly
different (US $1439 vs $1477) (Table 4). Using our
endemic data as reference, the estimated average annual
cost for a patient requiring renal replacement therapy was
US $20,054.14,15 The annual risk for progression to renal
replacement therapy was 8.7% in the nonmultidisciplinary
care group. With a 36.0% risk reduction and a difference of
US $16,260 between chronic kidney disease and end-stage
renal disease, the annual cost savings attributed to less
renal replacement therapy was US $509. Therefore, weconcluded that the net savings per multidisciplinary care
patient was US $1931 annually (Table 4).DISCUSSION
Our analysis demonstrated better renal care for advanced
chronic kidney disease patients receiving multidisciplinary
care, with the risk reduction of 36.0% for renal replacement
therapy. This effect might be one of the important reasons
for the reduction of end-stage renal disease incidence in
Taiwan since 2007.10 The risk-reduction ratio in this study
is greater compared with the 15% decrease in end-stage
renal disease incidence in Taiwan. The main reason is that
only 47% of stage 3B-5 chronic kidney disease patients
were enrolled in this nationwide program until December
2013. If all patients are enrolled in the program, the decrease
of end-stage renal disease incidence in Taiwan might be
higher.
In our study, the effect of the multidisciplinary care
program was most prominent in stage 4 patients. For
stage 5 patients, the effect was not signiﬁcant due to rapid
entering into end stage. For stage 3B patients, it may take
longer to reach the endpoint. It was difﬁcult to see a
difference with short-term follow-up and limited patient
numbers. This phenomenon could also explain that
the beneﬁt of a multidisciplinary care program cannot
be easily observed in early chronic kidney disease
patients.5,6
Figure 2 Cumulative incidence of renal replacement therapy using Fine and Gray model accounting death as a competing risk.
Multidisciplinary care group had a better renal outcome. (A) In all patients. (B) Chronic kidney disease stage 3B patients. (C) Chronic
kidney disease stage 4 patients. (D) Chronic kidney disease stage 5 patients. eGFR ¼ estimated glomerular ﬁltration rate; MDC ¼
multidisciplinary care.
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many aspects13,16 and are quite complicated for patients and
health care staffs. This complexity may reduce the motiva-
tion of patients to follow the guidelines. Therefore,Table 2 Crude and Multivariate Adjusted Hazard Ratio of Renal Repl
Individual Stages
All P-Value Stage 3B P-Va
Univariate
analysis
0.675 (0.570-0.800) <.001 0.779 (0.413-1.471) .442
Multivariate
analysis
Model 1 0.641 (0.483-0.851) .002 0.531 (0.187-1.511) .236
Model 2 0.640 (0.484-0.847) .002 0.522 (0.195-1.395) .195
Fine and Gray regression model was used, accounting death as a competing
Model 1: Adjust age, sex, diabetes mellitus, cardiovascular disease, systolic bl
X phosphate, Log urine protein creatinine ratio.
Model 2: Adjust age, sex, diabetes mellitus, cardiovascular disease, systolic
creatinine ratio, angiotensin-converting enzyme inhibitor/angiotensin receptorsufﬁcient supervision is necessary to reach the goal. Our
study proved that multidisciplinary care program partici-
pants have signiﬁcantly better phosphate control. Phosphate
control is one of the indexes of medical compliance andacement Therapy for Multidisciplinary Care in All Patients and in
lue Stage 4 P-Value Stage 5 P-Value
0.465 (0.340-0.636) <.001 0.757 (0.610-0.939) .011
0.361 (0.213-0.612) <.001 0.810 (0.578-1.135) .221
0.375 (0.219-0.640) <.001 0.802 (0.576-1.118) .194
risk factor.
ood pressure, estimated glomerular ﬁltration rate (eGFR), albumin, calcium
blood pressure, eGFR, albumin, calcium X phosphate, Log urine protein
blocker.
Table 3 Secondary Outcomes and Medical Resource Use of Multidisciplinary Care and Nonmultidisciplinary Care Groups
Multidisciplinary Care Group Nonmultidisciplinary Care Group
P-ValueMean  SD Mean  SD
DeGFR (mL/min/1.73m2) 2.57  6.64 3.74  10.40 .021
DeGFR (Stage 3B) 1.02  7.69 2.06  9.88 .286
DeGFR (Stage 4) 2.84  7.01 4.47  13.47 .118
DeGFR (Stage 5) 3.76  4.62 4.30  6.71 .333
DSystolic blood pressure (mmHg) þ0.80  19.28 þ0.70  20.32 .935
DHemoglobin (g/dL) 0.11  1.50 0.24  1.70 .269
DAlbumin (g/dL) 0.06  0.42 þ0.00  0.55 .121
DPhosphate (mg/dL) þ0.03  0.88 þ0.33  1.47 .013
DUrine protein creatinine ratio (g/g) þ0.379  2.590 þ0.557  2.233 .474
Multidisciplinary Care Group
(Per Patient Year)
Nonmultidisciplinary Care Group
(Per Patient Year)
Cardiovascular admissions 0.04 0.10 <.001
Days 0.66 1.47 <.001
Infection admissions 0.07 0.12 <.001
Days 1.00 2.78 <.001
Emergent department visits 0.47 0.77 <.001
Outpatient visits 13.12 12.95 .910
n (%) n (%)
Emergent start of renal replacement therapy 91/230 (39.6%) 174/319 (54.5%) .001
Renal replacement therapy modality .060
Hemodialysis 148/230 (64.3%) 216/319 (67.7%)
Peritoneal dialysis 73/230 (31.7%) 100/319 (31.3%)
Transplantation 9/230 (3.9%) 3/319 (0.9%)
Start of hemodialysis .001
Temporary catheter 72/148 (48.6%) 143/216 (66.2%)
Tunneled catheter 7/148 (4.7%) 12/216 (5.6%)
AVF/AVG 69/148 (46.6%) 61/216 (28.2%)
Continuous variables were compared using t-test and categorical variables were compared using chi-squared test.
Event rates were compared by Poisson test.
Outpatient visits refer to visiting all specialties in our hospital, not just nephrology clinic.
AVF ¼ arteriovenous ﬁstula; AVG ¼ arteriovenous graft; DeGFR ¼ annual change of estimated glomerular ﬁltration rate.
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patients.17 Dietician consultation and nurse’s supervision
both contributed to good phosphate control by emphasizing
a low protein/phosphate diet18,19 and drug compliance for
phosphate binders.20 Both contributed to a lesser increase of
proteinuria21 and brought better outcomes in the multidis-
ciplinary care group.
The multidisciplinary care program also provided better
health care. In our study, we noticed a marked decrease in
infection and cardiovascular event compared with another
cohort.12 The need of unplanned dialysis was also lower, as
in other studies.11,12,22 It was noteworthy that the rate of
emergent start was high in our study and another cohort in
Taiwan12 despite emphasis on patient education. This might
be related to elder age in these cohorts, and reluctance of our
people to accept access preparation without overt uremic
symptoms. The frequency of outpatient visits between
groups was nearly the same. We could conclude that the
better outcome was not attributed to more intensive visits.
A higher percentage of patients in the multidisciplinary caregroup choose renal transplantation for long-term renal
replacement therapy. This difference illustrated another
aspect of improving patient care by better education in renal
replacement therapy modality selection.
Multidisciplinary care program is cost-effective in our
analysis. Compared with other cohorts,7,22 the outpatient
medical cost per person-year was not higher in the multi-
disciplinary care group. We assumed that it was attributed to
better disease control that could decrease cost. In addition,
the medical costs on emergency department and inpatient
treatment decreased signiﬁcantly in the multidisciplinary
care group. This phenomenon correlated with fewer car-
diovascular events, infection events, and less need of
unplanned dialysis.
There were several limitations in our study. First, this
was a retrospective observational cohort without randomi-
zation. Physicians’ preference and patients’ issue could
affect the result. However, there are ethical concerns about
performing a randomized control trial in Taiwan, because
it is probably beneﬁcial, and promoting the multidisciplinary
Table 4 Medical Costs of Multidisciplinary Care and Nonmultidisciplinary Care Group
Multidisciplinary Care Group
(Per Patient Year)
Nonmultidisciplinary Care Group
(Per Patient Year) P-Value
Total medical costs 2372  138 (2116w2522) 3794  259 (3234w3994) <.001
Emergent department 104  7 (99w121) 189  13 (174w212) <.001
Inpatient 829  57 (745w912) 2128  137 (1921w2379) <.001
Outpatient 1439  113 (1297w1629) 1477  61 (1362w1544) .767
Estimated savings by less renal replacement therapy 509
Net savings 1931
Medical costs were calculated with per person-year and expressed as mean  standard error (95% conﬁdence interval).
Outpatient visits refer to visiting all specialties in our hospital, not just nephrology clinic.
Chen et al Multidisciplinary Care Provides Better Care in Chronic Kidney Disease 75care program is our national policy. Therefore, we used
matching analysis in this study to adjust confounders to
minimize bias. Because of the easy access to medical care in
Taiwan and the high proportions of Taipei metropolitan
residents, the disparity of social background may be limited
between groups. All patients received standard nephrology
care with similar ACEI/ARB use rate. Second, this study
was performed in a single center. The result may not apply
to all patients. Comparing our results with the data from the
Taiwan Renal Registry Data System,10 the number of
patients enrolled in the multidisciplinary care program, and
the renal replacement therapy incidence as mentioned
above, all the data are similar. Therefore, we considered our
result cohort cogent and representative of the multidisci-
plinary care programs in Taiwan. Third, only the medical
costs in our hospital were included. However, as a tertiary
medical center, most of our chronic kidney disease patients
had all their diseases treated in our hospital. Therefore, we
hypothesized that the medical costs outside of the hospital
were few and equally distributed between groups.
Despite the limitations, the current study proved that the
multidisciplinary care program provided better health care
and reduced the incidence of long-term renal replacement
therapy in advanced chronic kidney disease patients. With
more patients enrolled in this nationwide program, we did
observe a concomitant decrease in end-stage renal disease
incidence in Taiwan. It was also cost-effective. We believe
that this program should be applied to all advanced chronic
kidney disease patients around the world.ACKNOWLEDGMENT
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